Edition:
United Kingdom

Fujifilm Holdings Corp (4901.T)

4901.T on Tokyo Stock Exchange

4,383JPY
26 Apr 2018
Change (% chg)

¥-14 (-0.32%)
Prev Close
¥4,397
Open
¥4,397
Day's High
¥4,402
Day's Low
¥4,368
Volume
878,900
Avg. Vol
1,695,243
52-wk High
¥4,838
52-wk Low
¥3,932

Latest Key Developments (Source: Significant Developments)

Icahn & Deason Provide Four-Part Plan To Increase Xerox Shareholder Value
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Carl Icahn And Darwin Deason::CARL ICAHN AND DARWIN DEASON RELEASE OPEN LETTER AND PRESENTATION TO XEROX SHAREHOLDERS.ICAHN & DEASON - PROVIDE FOUR-PART PLAN TO INCREASE XEROX SHAREHOLDER VALUE.CARL ICAHN & DARWIN DEASON SAY FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO RE-EVALUATE ASIA-PACIFIC MARKET WITH A "STRONGER MANAGEMENT TEAM".ICAHN & DEASON - FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO DRIVE BOTTOM-LINE COST SAVINGS THROUGH NETWORK CONSOLIDATION AND CHANNEL OPTIMIZATION.CARL ICAHN & DARWIN DEASON SAY FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO MONETIZE "UNTAPPED INTELLECTUAL PROPERTY".ICAHN AND DEASON SAYS FOUR-PART PLAN FOR XEROX INCLUDES PROPOSAL TO "UNLOCK GROWTH THROUGH NEW ADJACENT SERVICES AND PARTNERSHIPS".ICAHN & DEASON - "BELIEVE OUR PLAN COULD CREATE TOTAL VALUE OF $54 TO $64 PER SHARE" COMPARED TO ABOUT $28 PER SHARE IN THE PROPOSED FUJI TRANSACTION.CARL ICAHN & DARWIN DEASON SAY XEROX CAN DRIVE COST SAVINGS BY OPTIMIZING ITS WHOLLY-OWNED SUBSIDIARY, GLOBAL IMAGING SYSTEMS.CARL ICAHN & DARWIN DEASON SAY XEROX CAN ADD ANOTHER "POTENTIALLY SIGNIFICANT" REVENUE STREAM BY MONETIZING ITS PALO ALTO RESEARCH CENTER.  Full Article

Mylan, Biocon Seek To Accelerate Introduction Of Adalimumab Biosimilar In EU
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Biocon Ltd ::MYLAN, BIOCON SEEK TO ACCELERATE INTRODUCTION OF ADALIMUMAB BIOSIMILAR IN EU.  Full Article

Mylan Partners With Fujifilm Kyowa Kirin Biologics
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Mylan NV ::MYLAN PARTNERS WITH FUJIFILM KYOWA KIRIN BIOLOGICS TO COMMERCIALIZE BIOSIMILAR TO HUMIRA® (ADALIMUMAB).MYLAN NV - COMPANIES EXPECT TO RECEIVE A DECISION FROM EMA IN SECOND HALF OF 2018.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS GRANTS MYLAN AN EXCLUSIVE LICENSE TO COMMERCIALIZE ADALIMUMAB BIOSIMILAR IN EUROPE.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS IS ELIGIBLE TO RECEIVE A SUBSEQUENT COMMERCIALIZATION MILESTONE PAYMENT AND SALES ROYALTIES.MYLAN NV - FUJIFILM KYOWA KIRIN BIOLOGICS WILL RECEIVE AN UP-FRONT FEE UNDER DEAL.MYLAN NV -CO, FUJIFILM KYOWA KIRIN BIOLOGICS CONTINUE TO NEGOTIATE FOR COMMERCIALIZING PRODUCT IN ADDITIONAL TERRITORIES.MYLAN NV - UNDER AGREEMENT TERMS CO TO BE RESPONSIBLE FOR SALES ACTIVITY OF PRODUCT IN EUROPEAN COUNTRIES.MYLAN NV - CO, FUJIFILM KYOWA KIRIN BIOLOGICS EXPECT TO RECEIVE DECISION FROM EMA REGARDING MAA FOR PROPOSED BIOSIMILAR TO HUMIRA IN H2 2018.  Full Article

Fujifilm CEO: Can Overcome Opposition From Some Shareholders To Xerox Deal
Thursday, 29 Mar 2018 

March 29 (Reuters) - Fujifilm Holdings Corp <4901.T> CEO::CAN OVERCOME OPPOSITION FROM SOME SHAREHOLDERS TO XEROX DEAL.  Full Article

Fujifilm Gets Favorable Final Determination In U.S. ITC Case Against Sony
Friday, 9 Mar 2018 

March 9 (Reuters) - Fujifilm Holdings Corp <4901.T>::FUJIFILM CORPORATION RECEIVES A FAVORABLE FINAL DETERMINATION IN UNITED STATES ITC CASE AGAINST SONY CORPORATION.SAYS IS CONFIDENT IT HAS SUFFICIENT CAPACITY TO SATISFY DEMAND FOR LTO-7​.  Full Article

Fujifilm Shares Up More Than 11 Percent After Co Says To Take Over Xerox, To Cut 10,000 Jobs At Fuji Xerox
Wednesday, 31 Jan 2018 

Feb 1 (Reuters) - Fujifilm Holdings Corp <4901.T>::FUJIFILM SHARES UP MORE THAN 11 PERCENT AFTER CO SAYS TO TAKE OVER XEROX, TO CUT 10,000 JOBS AT FUJI XEROX.  Full Article

Xerox- Have Reviewed Letter From Deason And Believe His Assertions And Characterizations Are "False And Misleading"‍​
Thursday, 18 Jan 2018 

Jan 17 (Reuters) - :XEROX- HAVE REVIEWED LETTER FROM DEASON AND BELIEVE HIS ASSERTIONS AND CHARACTERIZATIONS ARE "FALSE AND MISLEADING"‍​.  Full Article

Darwin Deason Delivers Public Letter To The Xerox Board
Wednesday, 17 Jan 2018 

Jan 17 (Reuters) - Darwin Deason::DEASON DELIVERS PUBLIC LETTER TO THE XEROX BOARD OF DIRECTORS; FILES 13D.DARWIN DEASON SAYS DEMANDS THAT XEROX IMMEDIATELY DISCLOSE ITS EXISTING JOINT VENTURE AGREEMENT WITH FUJI.DARWIN DEASON SAYS DEMAND XEROX BOARD HIRE INDEPENDENT ADVISORS AFTER TALKS TO EVALUATE STRATEGIC OPTIONS WITH FUJI, INCLUDING POTENTIAL TERMINATION OF DEAL.DARWIN DEASON SAYS FOLLOWING XEROX'S DISCLOSURE OF AGREEMENT, "WE WILL SEEK FURTHER DISCUSSION WITH BOARD REGARDING THESE MATTERS".  Full Article

Fujifilm Recalls Power Adapter Wall Plugs Sold With Digital Cameras Due To Shock Hazard
Tuesday, 16 Jan 2018 

Jan 16 (Reuters) - U.S. Consumer Product Safety Commission::FUJIFILM RECALLS POWER ADAPTER WALL PLUGS SOLD WITH DIGITAL CAMERAS DUE TO SHOCK HAZARD.U.S. CONSUMER PRODUCT SAFETY COMMISSION SAYS FUJIFILM RECALLS ABOUT 270,000 POWER ADAPTER WALL PLUGS SOLD WITH DIGITAL CAMERAS DUE TO SHOCK HAZARD.  Full Article

Fujifilm Holdings buys back 2.8 mln shares for 12.89 bln yen
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Fujifilm Holdings Corp <4901.T>:Says it repurchased 2.8 million shares for 12.89 billion yen in total, from Dec. 1, 2017 to Dec. 29, 2017.Says this was part of the share repurchase plan announced on Aug. 30, 2017.Says it accumulatively repurchased 6.5 million shares for 29.41 billion yen in total, as of Dec. 29, 2017 .  Full Article

Deals of the day-Mergers and acquisitions

April 20 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Friday: ** Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. ** General Electric Co said it was still considering a potential breakup of the 126-year-old industrial conglomerate, but such a move was secondary to running its businesses bett